Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/10346
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNg, Steven-
dc.contributor.authorVillemagne, Victor L-
dc.contributor.authorBerlangieri, Salvatore U-
dc.contributor.authorLee, Sze-Ting-
dc.contributor.authorCherk, Martin H-
dc.contributor.authorGong, Sylvia J-
dc.contributor.authorAckermann, Uwe-
dc.contributor.authorSaunder, Tim-
dc.contributor.authorTochon-Danguy, Henri-
dc.contributor.authorJones, Gareth-
dc.contributor.authorSmith, Clare-
dc.contributor.authorO'Keefe, Graeme J-
dc.contributor.authorMasters, Colin L-
dc.contributor.authorRowe, Christopher C-
dc.date.accessioned2015-05-15T23:46:14Z
dc.date.available2015-05-15T23:46:14Z
dc.date.issued2007-04-01-
dc.identifier.citationJournal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine; 48(4): 547-52en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/10346en
dc.description.abstractAmyloid-beta (Abeta) imaging with N-methyl-(11)C-2-(4'-methylamino-phenyl)-6-hydroxy-benzothiazole ((11)C-6-OH-BTA-1; also known as (11)C-PIB) shows a robust increase in cortical binding in Alzheimer's disease (AD). The aim of this study was to explore the clinical potential of Abeta imaging for the diagnosis of AD by comparison of the accuracy of visual reading of (11)C-PIB images with quantitative analysis and (18)F-FDG.Fifteen AD patients (age, 71.1 +/- 11.3 y [mean +/- SD]; mini-mental state examination [MMSE], 18.9 +/- 9.3 [mean +/- SD]) and 25 healthy control (HC) subjects (age, 71.9 +/- 6.82 y; MMSE >or= 28) underwent 90-min dynamic (11)C-PIB PET and 20-min static (18)F-FDG PET. (11)C-PIB images, generated from data acquired between 40 and 70 min after injection, and (18)F-FDG images were rated separately by 2 readers as normal, possible AD, or probable AD. Quantitative analyses used the distribution volume ratio (DVR) of frontal cortex, parietotemporal cortex, posterior cingulate, and caudate nucleus for (11)C-PIB and standardized uptake value ratio (SUVR) of parietotemporal cortex and posterior cingulate for (18)F-FDG, using cerebellar cortex as the reference region. Receiver-operating-characteristic (ROC) analysis was performed to compare the accuracy of quantitative measures. To determine the effect of age on diagnostic accuracy, the median age of the AD subjects (74 y) was chosen to separate the cohort into younger (64.4 +/- 5.8 y) and older (78.6 +/- 4.1 y) groups.Visual agreement between readers was excellent for (11)C-PIB (kappa = 0.90) and good for (18)F-FDG (kappa = 0.56). (11)C-PIB was more accurate than (18)F-FDG both on visual reading (accuracy, 90% vs. 70%, P = 0.05) and ROC analysis (95% vs. 83%, P = 0.02). Accuracy declined more with (18)F-FDG than with (11)C-PIB in the older group.Visual analysis of (11)C-PIB images appears more accurate than visual reading of (18)F-FDG for identification of AD and has accuracy similar to quantitative analysis of a 90-min dynamic scan. The accuracy of (11)C-PIB PET is limited by cortical binding in some healthy elderly subjects, consistent with postmortem studies of cerebral Abeta. Longitudinal follow-up is required to determine if this represents detection of preclinical AD.en
dc.language.isoenen
dc.subject.otherAgeden
dc.subject.otherAlzheimer Disease.diagnosis.pathologyen
dc.subject.otherBenzothiazoles.pharmacokineticsen
dc.subject.otherBrain.pathologyen
dc.subject.otherCarbon Radioisotopes.pharmacokineticsen
dc.subject.otherCohort Studiesen
dc.subject.otherFemaleen
dc.subject.otherFluorodeoxyglucose F18.pharmacokineticsen
dc.subject.otherHumansen
dc.subject.otherImage Processing, Computer-Assisteden
dc.subject.otherMaleen
dc.subject.otherMiddle Ageden
dc.subject.otherModels, Statisticalen
dc.subject.otherObserver Variationen
dc.subject.otherROC Curveen
dc.titleVisual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease.en
dc.typeJournal Articleen
dc.identifier.journaltitleJournal of Nuclear Medicineen
dc.identifier.affiliationDepartment of Nuclear Medicine, Centre for PET, Austin Health, Heidelberg, Victoria, Australiaen
dc.description.pages547-52en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/17401090en
dc.type.contentTexten
dc.type.austinJournal Articleen
local.name.researcherAckermann, Uwe
item.grantfulltextnone-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptClinical Haematology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptThe Florey Institute of Neuroscience and Mental Health-
crisitem.author.deptMolecular Imaging and Therapy-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

38
checked on Nov 22, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.